Demonstration of this mutation and/or loss of immunohistochemical staining with SMARCA4 (BRG1) antibody may, in the correct morphological context, be crucial in the diagnosis of this highly aggressive neoplasm.99, 100, 101. The gene discussed is SMARCA4; the disease is neoplasm.